ReviewAmerican journal of obstetrics & gynecology MFM2023

What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

Tracy A Manuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.